NCT05309668 · OUTCOME

Adverse Events Graded by CTCAE Ver 5.0

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN · Source last updated 2026-08-13

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: from screening until 30 days after last dose

What was measured

To assess the safety and tolerability of the selumetinib granule formulation.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

anticipated Posting Date: 2027-11
denom Units Selected: Participants
description: To assess the safety and tolerability of the selumetinib granule formulation.
reporting Status: NOT_POSTED
time Frame: from screening until 30 days after last dose
title: Adverse Events Graded by CTCAE Ver 5.0
type: PRIMARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice